Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism, Coronary Thrombosis, and Myocardial Infarction in Middle-aged Finnish Men who Died Suddenly

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Thrombosis and Haemostasis

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0037-1613971PMID 10928474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predicting sudden death in the population: the Paris Prospective Study I.

  1999cited by this paper
• Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study.

  1999cited by this paper
• Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction.

  1999influential reference
• Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.

  1999cited by this paper
• Familial predisposition and susceptibility to the effect of other risk factors for myocardial infarction.

  1999cited by this paper
• Angiotensin I-converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort.

  1999cited by this paper
• Predicting Sudden Death in the Population

  1999cited by this paper
• Prothrombotic genetic risk factors in young survivors of myocardial infarction.

  1999cited by this paper
• Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males.

  1999cited by this paper
• The 4G4G Genotype of the Plasminogen Activator Inhibitor 4G/5G Gene Polymorphism Is Associated with Coronary Atherosclerosis in Patients at High Risk for this Disease

  1999cited by this paper
• Post-mortem cast angiography in the diagnostics of graft complications in patients with fatal outcome following coronary artery bypass grafting (CABG)

  1999cited by this paper
• The 4G/5G Polymorphism in the Plasminogen Activator Inhibitor-1 Gene Is not Associated with Myocardial Infarction

  1999influential reference
• PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants.

  1998cited by this paper
• Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men.

  1998cited by this paper
• Family history as a risk factor for primary cardiac arrest.

  1998cited by this paper
• Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population.

  1998cited by this paper
• The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.

  1998cited by this paper
• The 4G/5G Polymorphism of PAI-1 Promoter Gene and the Risk of Myocardial Infarction: A Meta-analysis

  1998cited by this paper
• Associations of Fibrinogen, Factor VII and PAI-1 with Baseline Findings among 10,500 Male Participants in a Prospective Study of Myocardial Infarction

  1998influential reference
• [Plasminogen activator inhibitor-1 in thrombotic disease].

  1998cited by this paper
• Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.

  1997cited by this paper
• Clot lysis: role of plasminogen activator inhibitors in haemostasis and therapy.

  1997cited by this paper
• Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

  1997influential reference
• Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.

  1997cited by this paper
• Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.

  1997cited by this paper
• Coronary risk factors and plaque morphology in men with coronary disease who died suddenly.

  1997cited by this paper
• Risk factors for sudden unexpected cardiac death in Tasmanian men.

  1997cited by this paper
• Plasminogen activator inhibitor-1 is a determinant of coronary thrombosis in sudden cardiac death

  1996cited by this paper
• Plasminogen Activator Inhibitor-1 (PAI-1) Promoter Polymorphism and Coronary Artery Disease in Non-Insulin-Dependent Diabetes

  1995cited by this paper
• The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study

  1995influential reference
• Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

  1995cited by this paper
• Genetic susceptibility to death from coronary heart disease in a study of twins.

  1994cited by this paper
• Coronary atherosclerosis : a multifactorial disease

  1993cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

  1992cited by this paper
• A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E.

  1990cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Family history of heart attack as an independent predictor of death due to cardiovascular disease.

  1984cited by this paper

• Case report of severe coronary artery disease complicated by malignant arrhythmia due to inherited thrombophilia

  2025cites this paper
• Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina

  2021cites this paper
• USF1 deficiency activates brown adipose tissue and improves cardiometabolic health

  2016cites this paper
• The Association between PAI-1 Gene Promoter Polymorphism and Serum Serpin E1, MDA, and Hs-CRP Levels in Coronary Artery Disease

  2016cites this paper
• The role of genetic markers of thrombophilia in the development of thrombosis after coronary artery bypass graft surgery

  2016cites this paper
• PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis.

  2015cites this paper
• PAI-1 4 G / 5 G polymorphism and coronary artery disease risk : a meta-analysis

  2015cites this paper
• The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis

  2014cites this paper
• Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis.

  2014cites this paper
• Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Allele Polymorphisms and NIDDM(Non-Insulin Dependent Diabetes Mellitus) Risk Factor for Early Onset Myocardial Infarction

  2014cites this paper
• Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.

  2012cites this paper
• RESISTÊNCIA À INSULINA E RISCO CARDIOVASCULAR: ASSOCIAÇÃO COM O POLIMORFISMO NO GENE PAI-1 E PARÂMETROS BIOQUÍMICOS EM MULHERES COM A SÍNDROME DOS OVÁRIOS POLICÍSTICOS

  2012cites this paper
• Frequency of thrombophilic genetic polymorphisms among Saudi subjects compared with other populations

  2012cites this paper
• PAI-1 4 G / 5 G Polymorphism and Plasma Levels Association in Patients with Coronary Artery Disease

  2011cites this paper
• PAI-1 4G/5G polymorphism and plasma levels association in patients with coronary artery disease.

  2011cites this paper
• Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction

  2010cites this paper
• Genetic Association and Interaction Analysis of USF1 and APOA5 on Lipid Levels and Atherosclerosis

  2010cites this paper
• Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey

  2010cites this paper
• Role of Genetic Polymorphism of Angiotensin-Converting Enzyme, Plasminogen Activator Inhibitor-1 and Endothelial Nitric Oxide Synthase in the Prognosis of Coronary Artery Disease

  2010cites this paper
• The I allele of the angiotensin converting enzyme I/D polymorphism confers protection against coronary artery disease

  2010cites this paper
• Reactive protein, plasminogen activator inhibitor type-1 (PAI-1) levels, PAI-1 promoter 4G/5G polymorphism and acute myocardial infarction

  2010cites this paper
• 4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries

  2010cites this paper
• Inferior Vena Cava Agenesia and a Massive Bilateral Iliofemoral Venous Thrombosis

  2008cites this paper
• Association Analysis of Allelic Variants of USF1 in Coronary Atherosclerosis

  2008cites this paper
• Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.

  2008cites this paper
• Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease

  2008cites this paper
• Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction

  2008cites this paper
• THE JEREMLAH METZGER LECTURE HYPERCOAGULABLE STATES: CHALLENGES AND OPPORTUNITIES

  2007cites this paper
• Interaction among 5,10 methylenetetrahydrofolate reductase, plasminogen activator inhibitor and endothelial nitric oxide synthase gene polymorphisms predicts the severity of coronary artery disease in Turkish patients

  2006cites this paper
• Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart disease

  2006cites this paper
• Candidate genetic markers and the risk of restenosis after coronary angioplasty.

  2004cites this paper
• Myeloperoxidase Gene Variation as a Determinant of Atherosclerosis Progression in the Abdominal and Thoracic Aorta: An Autopsy Study

  2003cites this paper
• Plasminogen Activator Inhibitor-1 Polymorphism in Women with Pre-eclampsia

  2003cites this paper
• [Tissue plasminogen activator and plasminogen activator inhibitor gene polymorphisms: possible relation to atherosclerosis and its complications].

  2003cites this paper
• The genetics of atherothrombotic disorders: a clinician's view

  2003cites this paper
• Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension.

  2003cites this paper
• Plasminogen activator inhibitor-1 and outcome after femoropopliteal angioplasty: analysis of genotype and plasma levels

  2003cites this paper
• The influence of genomics on outcome after cardiovascular surgery

  2002cites this paper
• The Relationship of Haemostatic System to the Vessel Wall, Thromboembolism, Atherosclerosis from Pathogenesis and Laboratory Standpoints.

  2002cites this paper
• Peroxisome Proliferator-Activated Receptor Ligands as Antiatherogenic Agents: Panacea or Another Pandora's Box?

  2002cites this paper
• Plasminogen Activator Inhibitor Type-1 (Part One): Basic Mechanisms, Regulation, and Role for Thromboembolic Disease

  2001cites this paper
• The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities.

  2001cites this paper
• The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities.

  2001cites this paper
• Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001.

  2001cites this paper
• Genetic Variation in Coagulation and Fibrinolytic Proteins and Their Relation With Acute Myocardial Infarction: A Systematic Review

  2001cites this paper